Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/ANTENGENE-CORPORATION-LIM-119080108/actualite/Antengene-Corporation-Limited-annonce-une-etude-de-phase-I-sur-l-anticorps-monoclonal-anti-CD24-ATG-44894692/?utm_source=whatsapp&utm_medium=social&utm_campaign=share